Italia markets open in 4 hours 22 minutes

Surrozen, Inc. (SRZN)

NasdaqCM - NasdaqCM Prezzo differito. Valuta in USD.
Aggiungi a watchlist
10,23+0,29 (+2,92%)
Alla chiusura: 04:00PM EDT
9,73 -0,50 (-4,89%)
Dopo ore: 04:00PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente9,94
Aperto9,90
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno9,62 - 10,45
Intervallo di 52 settimane4,50 - 16,19
Volume9.626
Media Volume17.151
Capitalizzazione34,163M
Beta (5 anni mensile)0,88
Rapporto PE (ttm)N/D
EPS (ttm)-21,33
Prossima data utili07 ago 2024 - 12 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A33,00
  • GlobeNewswire

    Surrozen Provides Second Quarter 2023 Financial Results

    SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers continues to enroll with safety data expected by the end of 2023 SZN-1326 Phase 1a clinical trial in healthy volunteers continues to enroll with safety data expected by the end of 2023 Corporate prioritization efforts expected to provide cash runway extension into 2025 SOUTH SAN FRANCISCO, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company

  • GlobeNewswire

    Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke

    In a preclinical model of ischemic stroke, systemic delivery of a selective Fzd4 Wnt antibody strongly reduced blood-brain-barrier leakage, death of surrounding brain tissue, tissue swelling, while improving neurologic scoreResults highlight potential of selective Fzd4 Wnt antibody for central nervous system disorders involving an abnormal blood-brain-barrier SOUTH SAN FRANCISCO, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Nasdaq: SRZN), a company pioneering targeted therapeutics t